Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan.
Sugauchi F, Orito E, Ohno T, Tanaka Y, Ozasa A, Kang JH, Toyoda J, Kuramitsu T, Suzuki K, Tanaka E, Akahane Y, Ichida T, Izumi N, Inoue K, Hoshino H, Iino S, Yotsuyanagi H, Kakumu S, Tomita E, Okanoue T, Nishiguchi S, Murawaki Y, Hino K, Onji M, Yatsuhashi H, Sata M, Miyakawa Y, Ueda R, Mizokami M. Sugauchi F, et al. Among authors: iino s. Hepatol Res. 2006 Oct;36(2):107-14. doi: 10.1016/j.hepres.2006.06.001. Epub 2006 Sep 7. Hepatol Res. 2006. PMID: 16956789
Timing of interferon therapy and sources of infection in patients with acute hepatitis C.
Ogata K, Ide T, Kumashiro R, Kumada H, Yotsuyanagi H, Okita K, Akahane Y, Kaneko S, Tsubouchi H, Tanaka E, Moriwaki H, Nishiguchi S, Kakumu S, Mizokami M, Iino S, Sata M. Ogata K, et al. Among authors: iino s. Hepatol Res. 2006 Jan;34(1):35-40. doi: 10.1016/j.hepres.2005.08.012. Epub 2005 Dec 15. Hepatol Res. 2006. PMID: 16359917
Prediction of treatment outcome with daily high-dose IFN alpha-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels: relationship of baseline viral levels and viral dynamics during and after therapy.
Iino S, Tomita E, Kumada H, Suzuki H, Toyota J, Kiyosawa K, Tanikawa K, Sata M, Hayashi N, Kakumu S, Matsushima T, Ohno T. Iino S, et al. Hepatol Res. 2004 Oct;30(2):63-70. doi: 10.1016/j.hepres.2004.07.002. Hepatol Res. 2004. PMID: 15519269
Low serum level of hepatitis B core-related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy.
Matsumoto A, Tanaka E, Minami M, Okanoue T, Yatsuhashi H, Nagaoka S, Suzuki F, Kobayashi M, Chayama K, Imamura M, Yotsuyanagi H, Nakaoka S, Maki N, Kawata S, Kumada H, Iino S, Kiyosawa K. Matsumoto A, et al. Among authors: iino s. Hepatol Res. 2007 Aug;37(8):661-6. doi: 10.1111/j.1872-034X.2007.00094.x. Hepatol Res. 2007. PMID: 17584261
533 results